Results for this period
Third quarter2023年10月1日〜2024年6月30日ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
高利益率のコロナ禍特需案件のカバーを既存事業で試みたものの、期初計画および前年同期を大きく下回った。シニアワーク事業ではBPO事業へのシフトが遅れ、シニアケア事業ではワクチン特需売上の剥落を既存事業の伸長で補った。
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2023年10月1日〜2024年6月30日 |
| Net Sales | ¥12,602 million (YoY -7.8%) |
| Operating profit | ¥332 million (YoY -22.6%) |
| Ordinary income | ¥312 million (YoY -27.3%) |
| Profit attributable to owners of the parent | ¥170 million (YoY -33.3%) |
| Net income per share | ¥20.00 |
| Equity ratio | End of the current fiscal period 40.5 / End of previous period 36.8 |
| Total assets | ¥4,664 million |
| Net assets | ¥1,926 million |
| Full-year earnings forecast | Net Sales ¥16,700 million (YoY -6.1%) / Operating profit ¥480 million (YoY -21.1%) / Ordinary income ¥450 million (YoY -25.4%) / Net income ¥219 million (YoY -42.2%) |
| Revision to Earnings Forecast | Net Sales Not disclosed → ¥16,700 million / Operating profit Not disclosed → ¥480 million / Ordinary income Not disclosed → ¥450 million / Net income Not disclosed → ¥219 million |
| Annual Dividend Forecast | ¥0 → ¥0(0.0%) |
| Segment revenue | Senior Work Business ¥2,003,478 thousand (YoY -47.7%) / Senior Care Business ¥10,598,745 thousand (YoY +7.8%) |
| Depreciation and amortization | ¥38,994 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on reversal of subscription rights to shares ¥15,724 thousand / Extraordinary loss Not disclosed |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Name of newly added company Not disclosed / Excluded 1 / Excluded Company Name 株式会社キャスト |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 8,624,320 Shares |
| Treasury Shares at Period-End | 118,600 Shares |
| Factors Behind Changes in Business Performance | 高利益率のコロナ禍特需案件のカバーを既存事業で試みたものの、期初計画および前年同期を大きく下回った。シニアワーク事業ではBPO事業へのシフトが遅れ、シニアケア事業ではワクチン特需売上の剥落を既存事業の伸長で補った。 |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.売上・利益への寄与が大きかった高利益率のコロナ禍特需案件を既存事業で補おうとしたものの、既存事業ではカバーしきれず、期初計画および前年同期を大きく下回った。シニアワーク事業ではBPO事業へのシフトが遅れ、シニアケア事業ではワクチン特需案件の剥落があった。